Dexamethasone bioavailability: Implications for DST research
- 31 March 1987
- journal article
- review article
- Published by Elsevier in Biological Psychiatry
- Vol. 22 (3) , 373-385
- https://doi.org/10.1016/0006-3223(87)90155-7
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Four definitions of endogenous depression and the dexamethasone suppression testJournal of Affective Disorders, 1985
- FALSE NORMAL DEXAMETHASONE SUPPRESSION TEST AND INDOMETHACINThe Lancet, 1982
- Simultaneous Determination of Corticosterone, Hydrocortisone, and Dexamethasone in Dog Plasma Using High Performance Liquid ChromatographyJournal of Pharmaceutical Sciences, 1982
- The Dexamethasone Suppression Test for MelancholiaThe British Journal of Psychiatry, 1982
- Effect of smoking on prednisone, prednisolone, and dexamethasone pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Influence of phenylbutazone, mofebutazone and aspirin on the pharmacokinetics of dexamethasone in the ratEuropean Journal of Drug Metabolism and Pharmacokinetics, 1981
- Cortisol metabolism in lymphocytes isolated from patients with different diseases (multiple sclerosis, Cushing's disease, and inflammatory diseases)The Journal of Steroid Biochemistry and Molecular Biology, 1980
- High Performance Liquid Chromatographic Assay of Dexamethasone in Plasma and TissueTherapeutic Drug Monitoring, 1980
- Disposition of synthetic glucocorticoids I. Pharmacokinetics of dexamethasone in healthy adultsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- The metabolism of dexamethasone in the rat—Effect of phenytoinJournal of Steroid Biochemistry, 1975